Department of Biology, Maynooth University, National University of Ireland, Maynooth, Co Kildare, Ireland.
Int J Mol Med. 2017 Oct;40(4):1078-1088. doi: 10.3892/ijmm.2017.3082. Epub 2017 Jul 27.
Supramolecular membrane complexes of low abundance are difficult to study by routine bioanalytical techniques. The plasmalemmal complex consisting of sarcoglycans, dystroglycans, dystrobrevins and syntrophins, which is closely associated with the membrane cytoskeletal protein dystrophin, represents such a high‑molecular‑mass protein assembly in skeletal muscles. The almost complete loss of the dystrophin isoform Dp427‑M and concomitant reduction in the dystrophin‑associated glycoprotein complex is the underlying cause of the highly progressive neuromuscular disorder named Duchenne muscular dystrophy. This gives the detailed characterization of the dystrophin complex considerable pathophysiological importance. In order to carry out a comprehensive mass spectrometric identification of the dystrophin‑glycoprotein complex, in this study, we used extensive subcellular fractionation and enrichment procedures prior to subproteomic analysis. Mass spectrometry identified high levels of full‑length dystrophin isoform Dp427‑M, α/β‑dystroglycans, α/β/γ/δ‑sarcoglycans, α1/β1/β2‑syntrophins and α/β‑dystrobrevins in highly purified sarcolemma vesicles. By contrast, lower levels were detected in transverse tubules and no components of the dystrophin complex were identified in triads. For comparative purposes, the presence of organellar marker proteins was studied in crude surface membrane preparations vs. enriched fractions from the sarcolemma, transverse tubules and triad junctions using gradient gel electrophoresis and on‑membrane digestion. This involved the subproteomic assessment of various ion‑regulatory proteins and excitation‑contraction coupling components. The comparative profiling of skeletal muscle fractions established a relatively restricted subcellular localization of the dystrophin‑glycoprotein complex in the muscle fibre periphery by proteomic means and clearly demonstrated the absence of dystrophin from triad junctions by sensitive mass spectrometric analysis.
低丰度的超分子膜复合物很难通过常规生物分析技术进行研究。质膜复合物由肌聚糖、 dystroglycans、 dystrobrevins 和 syntrophins 组成,与膜细胞骨架蛋白 dystrophin 密切相关,是骨骼肌中这种高分子质量蛋白组装体的代表。几乎完全丧失 dystrophin 同工型 Dp427-M 和随之而来的 dystrophin 相关糖蛋白复合物的减少是导致称为杜氏肌营养不良症的高度进行性神经肌肉疾病的根本原因。这使得 dystrophin 复合物的详细特征具有相当重要的病理生理学意义。为了对 dystrophin-糖蛋白复合物进行全面的质谱鉴定,在本研究中,我们在亚蛋白质组分析之前使用了广泛的亚细胞分级和富集程序。质谱鉴定了高度纯化的肌膜小泡中高水平的全长 dystrophin 同工型 Dp427-M、α/β-dystroglycans、α/β/γ/δ-sarcoglycans、α1/β1/β2-syntrophins 和α/β-dystrobrevins。相比之下,在横小管中检测到的水平较低,在三联体中未鉴定出 dystrophin 复合物的任何成分。为了进行比较,使用梯度凝胶电泳和膜上消化,在粗表面膜制剂与肌膜、横小管和三联体连接处的富集部分之间研究了细胞器标记蛋白的存在。这涉及各种离子调节蛋白和兴奋-收缩偶联成分的亚蛋白质组评估。骨骼肌部分的比较分析通过蛋白质组学方法确定了 dystrophin-糖蛋白复合物在肌肉纤维周围的相对受限的亚细胞定位,并通过敏感的质谱分析清楚地证明了 dystrophin 不存在于三联体连接处。